CET-028

N/A

Report date: 2025/01/26 17:52:46
NME

Base Information

Drug NameCET-028
Drug Alias Nametriple-negative breast cancer program (Oregon Health Sciences University/Stanford University School of Medicine)CET-028
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOregon Health And Science University
China Registration ClassN/A

Develop Information

Active CompaniesOregon Health And Science UniversityStanford University School of Medicine
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A